Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration
Clinical trial NCT04047472 · COMPLETED
Trial details
- NCT number
- NCT04047472
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-29
- Primary completion
- 2024-02-28
- Enrollment
- 397
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.